Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Cancer Invest. 2008 Nov;26(9):956–963. doi: 10.1080/07357900802132550

Table 4.

Comparison of peripheral sensory neuropathy

During treatment (%) Six months after treatment (%) 4-year follow-up (%)
NCI CTC AEa Grades FOLFOXb N=1106 FLOXc N=1189 FOLFOXb N=1058 FLOXc N= 1030 FOLFOXd N=811 FLOX
    Grade 0 7.9 21.3 59.0 71.4 84.3 NAe
    Grade 1 48.2 52.1 31.9 23.4 12.0 NA
    Grade 2 31.6 19.8 7.8 4.8 2.8 NA
    Grade 3 12.4 6.7 1.3 0.5 0.7 NA
    Grade 4 0.2a 0a
a

NSABP C-07 used CTCAE version 2.0, that grades neurosensory from 0–4. MOSAIC used CTCAE version 1.0, which grades neurosensory from 0–3.

b

André, T et al. N Eng J Med. 2004, 350:2343–2351.

c

Unpublished data, Greg Yothers, PhD. (NSABP Biostatistical Center)

d

de Gramont, A et al. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007, (Abstr 4007).

e

NA = Not available.